QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 2, 2005, 25(44):10321-10335; doi:10.1523/JNEUROSCI.4014-05.2005

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (32) Citing Articles via Google Scholar Google Scholar Articles by Shih, A. Y. Articles by Murphy, T. H. Search for Related Content PubMed PubMed Citation Articles by Shih, A. Y. Articles by Murphy, T. H. Pubmed/NCBI databases Medline Plus Health Information Antioxidants

 Previous Article

Neurobiology of Disease
A Small-Molecule-Inducible Nrf2-Mediated Antioxidant Response Provides Effective Prophylaxis against Cerebral Ischemia In Vivo

Andy Y. Shih,¹ Ping Li,¹ and Timothy H. Murphy^1,2

Departments of ¹Psychiatry and ²Physiology, Kinsmen Laboratory of Neurological Research and Brain Research Center, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3

The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) coordinates expression of genes required for free radical scavenging, detoxification of xenobiotics, and maintenance of redox potential. Previously, activation of this pleiotropic response was neuroprotective in cell culture models that simulate components of stroke damage. However, the role of Nrf2 in limiting stroke damage in vivo remained unclear. We report that Nrf2 activation protects the brain from cerebral ischemia in vivo. Acute (1-3 d) intracerebroventricular or intraperitoneal pretreatment with tert-butylhydroquinone (tBHQ), an Nrf2 activity inducer, reduced cortical damage and sensorimotor deficit at 24 h and even 1 month after ischemia-reperfusion in rats. Cortical glutathione levels robustly increased with tBHQ administration to rats and Nrf2-expressing mice, but not Nrf2^-/- mice. Basal and inducible activities of antioxidant/detoxification enzymes in Nrf2^-/- mice were reduced when compared with Nrf2^+/+ controls. Interestingly, larger infarcts were observed in Nrf2^-/- mice at 7 d after stroke, but not at 24 h, suggesting that Nrf2 may play a role in shaping the penumbra well after the onset of ischemia. Neuronal death caused by a "penumbral" model of stroke, using intracortical endothelin-1 microinjection, was attenuated by tBHQ administration to Nrf2^+/+, but not to Nrf2^-/- mice, confirming the Nrf2-specific action of tBHQ in vivo. We conclude that Nrf2 plays a role in modulating ischemic injury in vivo. Accordingly, Nrf2 activation by small molecule inducers may be a practical preventative treatment for stroke-prone patients.

Key words: Nrf2; NF-E2-related factor; astrocyte; tert-butylhydroquinone; antioxidant response element; NAD(P)H:quinone oxidoreductase; glutathione; oxidative stress; neuroprotection; stroke; ischemia; brain; endothelin-1

---

Received Nov 5, 2004; accepted September 23, 2005.

This article has been cited by other articles:

				P.-C. Chen, M. R. Vargas, A. K. Pani, R. J. Smeyne, D. A. Johnson, Y. W. Kan, and J. A. Johnson Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte PNAS, February 24, 2009; 106(8): 2933 - 2938. [Abstract] [Full Text] [PDF]

				M. R. Vargas, D. A. Johnson, D. W. Sirkis, A. Messing, and J. A. Johnson Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis J. Neurosci., December 10, 2008; 28(50): 13574 - 13581. [Abstract] [Full Text] [PDF]

				X. Zhao, G. Sun, J. Zhang, R. Strong, P. K. Dash, Y. W. Kan, J. C. Grotta, and J. Aronowski Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage Stroke, December 1, 2007; 38(12): 3280 - 3286. [Abstract] [Full Text] [PDF]

				A. F. Hubbs, S. A. Benkovic, D. B. Miller, J. P. O'Callaghan, L. Battelli, D. Schwegler-Berry, and Q. Ma Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2 Am. J. Pathol., June 1, 2007; 170(6): 2068 - 2076. [Abstract] [Full Text] [PDF]

				M. S. Yates, M. Tauchi, F. Katsuoka, K. C. Flanders, K. T. Liby, T. Honda, G. W. Gribble, D. A. Johnson, J. A. Johnson, N. C. Burton, et al. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther., January 1, 2007; 6(1): 154 - 162. [Abstract] [Full Text] [PDF]

				A. Y. Shih, H. Erb, X. Sun, S. Toda, P. W. Kalivas, and T. H. Murphy Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation J. Neurosci., October 11, 2006; 26(41): 10514 - 10523. [Abstract] [Full Text] [PDF]

				X. Sun, A. Y. Shih, H. C. Johannssen, H. Erb, P. Li, and T. H. Murphy Two-photon Imaging of Glutathione Levels in Intact Brain Indicates Enhanced Redox Buffering in Developing Neurons and Cells at the Cerebrospinal Fluid and Blood-Brain Interface J. Biol. Chem., June 23, 2006; 281(25): 17420 - 17431. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help